FDA 483 - Temrex Corporation - June 25, 2021

An FDA inspection of Temrex Corporation, a medical device manufacturer and importer in Freeport, NY, revealed significant deficiencies in its quality system. Observations included failures to maintain written Medical Device Reporting procedures and inadequately maintained device history records. Additionally, the firm lacked proper documentation approval for standard operating procedures and failed to establish requirements for suppliers and contractors.